Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/AKTX/Revenue

Akari Therapeutics Plc (AKTX) Revenue 2022–2023

Akari Therapeutics Plc (AKTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$367,877FY2023 · since FY2022: $607,681 → $367,877
2223
Fiscal yearValueYoY
FY2023$367,877-39.5%
FY2022$607,681—

Source: SEC XBRL filings · For reference only · Not investment advice

More AKTX financial trends

AKTX Net incomeAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →